Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Phreesia Inc reports robust Q3 earnings, eyes sustained growth

Phreesia Inc's Q3 performance reflects strong financial results and positive cash flows, underpinning its growth trajectory.
The company's revised outlooks for fiscal 2025 and initial guidance for 2026 signal confidence in sustained growth and profitability.
While balancing profitability and reinvestment poses challenges, Phreesia has opportunities to leverage network solutions, customer feedback, and strategic leadership for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Cognex

Fiverr

ROBO Global Healthcare Technology and Innovation ETF

SPDR S&P Kensho New Economies Composite ETF

Global X Internet of Things ETF

Vanguard Russell 2000 Growth 

These seven innovative stocks, and ETFs that hold such stocks, could have significant growth potential in the months ahead. The post 7 Innovative Stocks That Will Disrupt Their Sectors appeared first on InvestorPlace.

7 Innovative Stocks That Will Disrupt Their Sectors

NEW YORK--(BUSINESS WIRE)--Phreesia, the nation’s leading patient intake platform, is pleased to announce that it has acquired two web-based workflow applications co-developed by Geisinger, a large health system based in Danville, Pa., and Merck, known as MSD outside of the USA and Canada. The newly acquired applications are designed to help improve patient communication and care delivery. The Family Caregiver application facilitates two-way communications and coordination of care for oncology

Phreesia Acquires Co-Developed Patient Care Applications by Merck and Geisinger

Phreesia, Inc. (PHR) CEO Chaim Indig on Q2 2021 Results - Earnings Call Transcript

Shares of Phreesia (NYSE:PHR) fell 6.17% in after-market trading after the company reported Q2 results.

Phreesia: Q2 Earnings Insights

NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the second quarter ended July 31, 2020.

Phreesia Announces Fiscal Second Quarter 2021 Results

CARY, N.C. & NEW YORK--(BUSINESS WIRE)--Community Care Physician Network (CCPN), the largest independent physician-led network in North Carolina, and Phreesia, the nation’s leading patient intake platform, are excited to announce they have partnered to offer patients a safer and more personalized patient experience. CCPN is leveraging Phreesia’s automated registration, clinical and communications applications to reduce exposure between patients and staff during intake, as well as to address pat

Phreesia Partners with Community Care Physician Network to Deliver a Safer, More Engaging Patient Experience and Address Unmet Social Needs

NEW YORK--(BUSINESS WIRE)--Phreesia, (NYSE: PHR) the nation’s leading patient intake platform, has named Allison Hoffman as its General Counsel, effective August 24. Hoffman joins Phreesia from Intersection, a digital technology company focused on improving life in cities and public spaces, where she served as Chief Legal & Administrative Officer since 2016.

Phreesia Names Allison Hoffman as General Counsel

NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company’s fiscal second quarter 2021 financial results after the close of market trading on Tuesday, September 8, 2020.

Phreesia Sets Release Date for Fiscal Second Quarter 2021 Results

NEW YORK--(BUSINESS WIRE)--Phreesia, the nation’s leading patient intake platform, is proud to announce it has partnered with AdventHealth, one of the nation’s largest faith-based healthcare systems, to provide patients with a safe, contactless intake experience across more than 1,000 AdventHealth hospitals, physician practices and urgent care centers. “Using Phreesia has helped us scale an intake workflow that reduces exposure between patients and staff during in-person visits,” said Jessica B

Phreesia Partners with AdventHealth to Provide Zero-Contact Intake Across its Hospital and Ambulatory Care Settings

NEW YORK--(BUSINESS WIRE)--Phreesia, the nation’s leading patient intake management platform, is pleased to announce it has named Lainie Goldstein as the newest member of its board of directors, effective July 20. Ms. Goldstein is the Chief Financial Officer of Take-Two Interactive Software, Inc.

Phreesia Names Lainie Goldstein CFO of Take-Two Interactive Software, to its Board of Directors

NEW YORK--(BUSINESS WIRE)--Phreesia, the nation’s leading patient intake management platform, is excited to announce it has been selected by Modern Healthcare as one of the 2020 Best Places to Work in Healthcare for the fourth time. “It’s an honor to be named to this prestigious list once again,” said Phreesia CEO Chaim Indig.

Phreesia Selected as One of Modern Healthcare’s “Best Places to Work in Healthcare” for the Fourth Time

Phreesia, Inc. (PHR) CEO Chaim Indig on Q1 2021 Results - Earnings Call Transcript

Phreesia Adapts To New Operating Environment But Visibility Awaits

Phreesia (PHR) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Phreesia (PHR) Soars: Stock Adds 6.8% in Session

Phreesia, Inc. (PHR) CEO Chaim Indig on Q4 2020 Results - Earnings Call Transcript

The healthcare software company scored another major customer addition last month.

Why Phreesia Stock Climbed 16.4% in January

Phreesia Inc’s (NYSE: PHR) stock is a way for investors to gain exposure to growing health care consumerism in the United States, according to KeyBanc Capital Markets.

KeyBanc Initiates Phreesia With Bullish Rating On Trend Of 'Healthcare Consumerism'

Phreesia, Inc. (PHR) CEO Chaim Indig on Q3 2020 Results - Earnings Call Transcript

Phreesia, Inc. (PHR) CEO Chaim Indig on Q2 2020 Results - Earnings Call Transcript

Livongo Health Inc

Here's why you'll want to keep both eyes on these market leaders.

2 New Digital Health Stocks for Your Watch List

Phreesia (NYSE: PHR) made its public debut Thursday morning, opening at $26.75 after being priced at $18 per share.

News for Phreesia Inc Stock (PHR)